The serum adiponectin levels were lowest in NAFLD patients. The serum MCP-1 levels were lowest in the obese without NAFLD. VAT expression of Omentin, SFRP4 with low chemerin expression in NAFLD with no difference in MCP-1. This evidence concerns the gene SFRP4 and metabolic dysfunction-associated steatotic liver disease.